Related Experiment Video
Updated: May 15, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
Genome-wide epigenetic regulation of miRNAs in cancer
Constance Baer1, Rainer Claus, Christoph Plass
1Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Abstract:
Aberrant microRNA (miRNA) expression contributes to tumorigenesis and cancer progression. Although the number of reported deregulated miRNAs in various cancer types is growing fast, the underlying mechanisms of aberrant miRNA regulation are still poorly studied. Epigenetic alterations including aberrant DNA methylation deregulate miRNA expression, which was first shown by reexpression of miRNAs upon pharmacologic DNA demethylation. However, studying the influence of DNA methylation on miRNA transcription on a genome-wide level was hampered by poor miRNA promoter annotation. Putative miRNA promoters were identified on a genome-wide level by using common promoter surrogate markers (e.g., histone modifications) and were later validated as such in different tumor entities. Integrating promoter datasets and global DNA methylation analysis revealed an extensive influence of DNA hyper- as well as hypomethylation on miRNA regulation. In this review, we summarize the current knowledge of the field and discuss recent efforts to map miRNA promoter sequences and to determine the contribution of epigenetic mechanisms to the regulation of miRNA expression. We discuss examples of tumor suppressive and oncogenic miRNAs such as the miR-34 and miR-21 family, respectively, which highlight the complexity and consequences of epigenetic miRNA deregulation.
Insights
Aberrant DNA methylation significantly impacts microRNA (miRNA) expression in cancer. This review highlights how epigenetic changes, particularly DNA methylation, influence tumor suppressive and oncogenic miRNAs, impacting cancer progression.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- Aberrant microRNA (miRNA) expression is a hallmark of cancer.
- Mechanisms driving miRNA dysregulation, especially epigenetic factors, remain underexplored.
- DNA methylation is a key epigenetic mechanism influencing gene expression.
Purpose of the Study:
- To review the current understanding of epigenetic regulation of miRNA expression in cancer.
- To highlight the role of DNA methylation in aberrant miRNA expression.
- To discuss challenges and advancements in mapping miRNA promoters for genome-wide analysis.
Main Methods:
- Genome-wide identification of miRNA promoters using surrogate markers like histone modifications.
- Integration of promoter datasets with global DNA methylation analysis.
- Review of existing literature on epigenetic miRNA regulation and specific miRNA examples.
Main Results:
- DNA hypermethylation and hypomethylation extensively influence miRNA transcription.
- Advancements in miRNA promoter annotation enable genome-wide studies.
- Epigenetic deregulation affects both tumor suppressive (e.g., miR-34) and oncogenic (e.g., miR-21) miRNAs.
Conclusions:
- Epigenetic alterations, particularly DNA methylation, are critical drivers of aberrant miRNA expression in cancer.
- Understanding these mechanisms is crucial for deciphering cancer progression and developing therapeutic strategies.
- Further research into miRNA promoter mapping and epigenetic regulation is essential.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
MicroRNAs
MicroRNAs
MicroRNAs

